Navigation Links
Tarantula venom-based MD therapy to be advanced by UB scientists' biotech company
Date:12/29/2009

BUFFALO, N.Y. -- University at Buffalo biophysicists have found a protein in tarantula venom that shows promise as a potential therapy for muscular dystrophy (MD). They have formed a start-up biotech company in Buffalo -- Rose Pharmaceuticals -- to advance the drug to clinical trials.

Fredrick Sachs, PhD, professor of physiology and biophysics at the University at Buffalo, and colleagues in his laboratory, discovered the peptide, called GsMTx4.

Therapies for muscular dystrophy are classed as "orphan drugs" by the FDA, allowing a shorter testing period than normal drugs. Sachs said he anticipates Rose Pharmaceuticals may be able to obtain FDA approval of the peptide for human use within two years.

The new company is named for "Rose," the pet tarantula that has been in residence in Sachs' lab for nearly 20 years.

The first target of the peptide is MD, a condition Sachs has been investigating for several years, but the peptide also has potential as a therapy for several other conditions, such as neuropathic pain and atrial fibrillation. Formation of the company was motivated by the goal of finding an MD therapy for the grandson of Sachs' friend Jeffrey Harvey.

The start-up is a collaboration between Sachs, Harvey, Thomas Suchyna, PhD, and Philip Gottlieb, PhD. Suchyna and Gottlieb, UB research scientist and UB research associate professor, respectively, have been working with Sachs at the university for several years to develop the peptide. Their work was supported by a grant from UB's Interdisciplinary Research and Creative Activities Fund.

In collaboration with Eric Hoffman, PhD, director of the Wellstone Muscular Dystrophy Center at Children's National Medical Center in Washington, D.C., the team tested the effect of GsMTx4 on MD mice extensively. Results showed that the drug increased muscle strength and caused no mortality, morbidity or toxicity.

Rose Pharmaceuticals now is concentrating on developing methods to a
'/>"/>

Contact: Lois Baker
ljbaker@buffalo.edu
716-645-4606
University at Buffalo
Source:Eurekalert

Page: 1 2

Related biology news :

1. Successful stem cell therapy for treatment of eye disease
2. Gene therapy and stem cells save limb
3. New therapy targets for amyloid disease
4. New understanding about mechanism for cell death after stroke leads to possible therapy
5. Duke develops nano-scale drug delivery for chemotherapy
6. Caltech researchers show efficacy of gene therapy in mouse models of Huntingtons disease
7. USU scientists report major advance in human antibody therapy against deadly Nipah virus
8. Patients in Europe benefit from new radiation therapy
9. LX211 highlighted as potential disease modifying therapy for non-infectious uveitis
10. Research needed to learn which DCIS patients may be candidates for less invasive therapy
11. IRSF announces funding of first clinical trial with disease-modifying therapy for Rett syndrome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/23/2014)... New University of Toronto Scarborough research shows that male ... well-fed virgins a rare example of mate preference ... by UTSC post-doc Emily MacLeod and Maydianne Andrade, a ... both controlled field studies and the wild that males ... also found male black widows can tell whether a ...
(Date:4/23/2014)... a unique rhythmic sound, recorded for decades in the ... minke whale ( Balaenoptera bonaerensis ). First described and ... it sounded like a duck, the bio-duck sound has ... but its source has remained a mystery, until now. ... deployed acoustic tags on two Antarctic minke whales in ...
(Date:4/23/2014)... accurate group decision increases with the abundance of brains ... a variety of factors as often happens in ... smaller groups actually tend to make more accurate decisions ... certain pieces of information. , The findings present a ... or the "wisdom of crowds," wherein individual observations ...
Breaking Biology News(10 mins):Picky male black widow spiders prefer well-fed virgins 2Scientists identify source of mysterious sound in the Southern Ocean 2Scientists identify source of mysterious sound in the Southern Ocean 3Too many chefs: Smaller groups exhibit more accurate decision-making 2Too many chefs: Smaller groups exhibit more accurate decision-making 3
... normally shut down during Huntington's disease, researchers at the ... have cured fruit flies of the genetic, neurodegenerative condition. ... as CREB and HSP-70--exist in all cells, including those ... by the Proceedings of the National Academy of Sciences, ...
... to study whether high hydrostatic pressure will inactivate Hepatitis ... The project, led by Daniel Holliman, an M.D. with ... manager, will identify one or more effective high pressure ... Department of Food Science and Technology at Virginia Tech, ...
... and flies keeps blood sugar under control in mice, ... The findings suggest therapeutic interventions for the prevention and ... which frequently arise with age, the researchers said. , ... the protein Sirt1 in cells of the pancreas have ...
Cached Biology News:Huntington's cure in flies lays groundwork for broader treatment approaches 2Use of high hydrostatic pressure to inactivate Hepatitis A virus in oysters studied 2Life-extending protein keeps blood sugar in check 2
(Date:1/15/2014)... The Pittcon Organizing Committee is pleased to announce that ... an e-Journal and producer of Food Labs Conference ... for the co-location of Food Labs Conference to be held ... registration fee to attend the two-day Food Lab Conference, March ...
(Date:1/15/2014)... Jan. 15, 2014 ­ RedBrick Health , a ... technology, today announces that EmblemHealth , the ... company, is now providing the RedBrick Compass health assessment, ... to all of its members. EmblemHealth is among the ...
(Date:1/15/2014)... Rochester, NY (PRWEB) January 15, 2014 The ... cause a major disease. One of these latent viruses is ... is rheumatoid arthritis (RA). Rheumatoid arthritis (RA) is a chronic ... the theory, a study found that RA patients have high ...
(Date:1/15/2014)... Biotechnology Company, Limited ("TaiGen") today announced that they have ... pharmaceutical company, to develop and commercialize nemonoxacin (Taigexyn ® ... Turkey and other members of ... for the treatment of bacterial infections including those caused ...
Breaking Biology Technology:Pittcon Announces Second Year Partnership With Food Safety Tech 2Pittcon Announces Second Year Partnership With Food Safety Tech 3EmblemHealth Selects RedBrick Health to Power its Next-Generation Health Engagement and Behavior Change System 2EmblemHealth Selects RedBrick Health to Power its Next-Generation Health Engagement and Behavior Change System 3Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4
... (Nasdaq: MSHL ) will present at the BIO ... Thursday, October 11, 2007 at 12:00 pm. About ... MSHL ) is a specialist oncology company,focused on the ... flavonoid technology platform which has generated a,number of novel ...
... PRXL ) will release First Quarter Fiscal Year ... close of the,stock market. The announcement will be available ... PR Newswire website at http://www.prnewswire.com . PAREXEL ... 10:00 a.m. ET,on Thursday, October 25, 2007 to discuss ...
... more than 70 million,Generation Y employees starting to ... workplace, smart companies are paying,attention, providing these future ... wants and needs. (Photo: http://www.newscom.com/cgi-bin/prnh/20071003/AQW903 ) ... the global health care company,Abbott, which was recently ...
Cached Biology Technology:Marshall Edwards, Inc. to Present at BIO Investor Forum 2007 2Marshall Edwards, Inc. to Present at BIO Investor Forum 2007 3PAREXEL Announces Date of First Quarter Fiscal Year 2008 Earnings Release and Conference Call 2Abbott Named One of the 'Best Places to Launch a Career' by BusinessWeek 2Abbott Named One of the 'Best Places to Launch a Career' by BusinessWeek 3Abbott Named One of the 'Best Places to Launch a Career' by BusinessWeek 4
GOAT ANTI FRK...
...
... PCR Spots, Oligo Spots and complementary RNA ... microarray experiments. Use for glass array printing ... for reverse transcription, cDNA labeling, hybridization stringency ... Control PCR Spots and Oligo Spots, ...
MOUSE ANTI DUCK IgY LIGHT CHAIN...
Biology Products: